MX2020004868A - Sistema de microagujas para la aplicacion de una vacuna contra la hepatitis. - Google Patents

Sistema de microagujas para la aplicacion de una vacuna contra la hepatitis.

Info

Publication number
MX2020004868A
MX2020004868A MX2020004868A MX2020004868A MX2020004868A MX 2020004868 A MX2020004868 A MX 2020004868A MX 2020004868 A MX2020004868 A MX 2020004868A MX 2020004868 A MX2020004868 A MX 2020004868A MX 2020004868 A MX2020004868 A MX 2020004868A
Authority
MX
Mexico
Prior art keywords
applying
microneedle system
hepatitis vaccine
hepatitis
microneedle
Prior art date
Application number
MX2020004868A
Other languages
English (en)
Inventor
Andreas Henning
Heiko Spilgies
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2020004868A publication Critical patent/MX2020004868A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/30—Vaccines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

El presente invento concierne a un sistema de microagujas (abreviado: SMA) para la aplicacion intradermica de una vacuna contra la hepatitis, concretamente el antigeno de superficie de la hepatitis B (HBsAg).
MX2020004868A 2017-11-10 2018-11-12 Sistema de microagujas para la aplicacion de una vacuna contra la hepatitis. MX2020004868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017126501.5A DE102017126501A1 (de) 2017-11-10 2017-11-10 Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
PCT/EP2018/080986 WO2019092257A1 (de) 2017-11-10 2018-11-12 Mikronadelsystem zur applikation eines hepatitis-impfstoffes

Publications (1)

Publication Number Publication Date
MX2020004868A true MX2020004868A (es) 2020-08-13

Family

ID=64564815

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004868A MX2020004868A (es) 2017-11-10 2018-11-12 Sistema de microagujas para la aplicacion de una vacuna contra la hepatitis.

Country Status (11)

Country Link
US (1) US12168053B2 (es)
EP (1) EP3706792A1 (es)
JP (2) JP2021502353A (es)
KR (1) KR20200087187A (es)
CN (1) CN111315410A (es)
AU (1) AU2018365396A1 (es)
BR (1) BR112020007980A2 (es)
CA (1) CA3082197A1 (es)
DE (1) DE102017126501A1 (es)
MX (1) MX2020004868A (es)
WO (1) WO2019092257A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102021118997A1 (de) 2021-07-22 2023-01-26 Lts Lohmann Therapie-Systeme Ag. Mikronadelarray mit Antiseptika

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595947B1 (en) 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US6589202B1 (en) * 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
KR100764699B1 (ko) 2000-09-08 2007-10-08 알자 코포레이션 경로 폐쇄 저해에 의한 경피 약물 플럭스 감소 저해방법
DE10353629A1 (de) 2003-11-17 2005-06-16 Lts Lohmann Therapie-Systeme Ag Vorrichtung zur transdermalen Verabreichung von Wirkstoffen
US20070106207A1 (en) * 2005-11-04 2007-05-10 Withey Edward L High-speed vaccination device
AU2008209537B2 (en) 2007-01-22 2013-01-31 Corium Pharma Solutions, Inc. Applicators for microneedle arrays
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
AU2008275743A1 (en) 2007-07-09 2009-01-15 Apogee Technology, Inc. Immunostimulating polyphosphazene compounds for intradermal immunization
EP3225247B1 (en) * 2010-05-28 2020-09-02 3M Innovative Properties Company Aqueous formulations for coating microneedle arrays
JP5808102B2 (ja) 2010-07-22 2015-11-10 コスメディ製薬株式会社 抗原を含有する経皮免疫製剤およびその製造方法
US20150057604A1 (en) * 2012-04-05 2015-02-26 Hisamitsu Pharmaceutical Co., Inc. Puncture Device and Method for Manufacturing Same
CN104027324B (zh) 2013-03-06 2017-12-15 中国科学院理化技术研究所 一种可溶性微针疫苗贴片及其制备方法
WO2015093452A1 (ja) 2013-12-16 2015-06-25 武田薬品工業株式会社 マイクロニードル
US20170065534A1 (en) * 2014-05-02 2017-03-09 The Research Foundation For The State University Of New York Compositions and methods for intradermal vaccine delivery
CN105311000B (zh) * 2014-06-27 2019-03-05 中科微针（北京）科技有限公司 自溶性微针透皮贴片及其制备方法
US10792042B2 (en) * 2015-01-15 2020-10-06 Ethicon, Inc. Circular staplers having resorbable microneedles containing active agents
JP2017051312A (ja) 2015-09-08 2017-03-16 富士フイルム株式会社 マイクロニードルアレイ
KR102494066B1 (ko) 2015-09-15 2023-01-31 주식회사 엘지생활건강 Ａ형 간염 예방 접종을 위한 용해성 미세바늘 패치
EP3412312B1 (en) 2016-02-03 2021-08-25 Cosmed Pharmaceutical Co., Ltd. Coating liquid for microneedles, microneedle-coating substance, and microneedle array

Also Published As

Publication number Publication date
WO2019092257A1 (de) 2019-05-16
CA3082197A1 (en) 2019-05-16
JP2021502353A (ja) 2021-01-28
RU2020116222A3 (es) 2022-03-23
DE102017126501A1 (de) 2019-05-16
AU2018365396A1 (en) 2020-05-14
US20210369839A1 (en) 2021-12-02
CN111315410A (zh) 2020-06-19
US12168053B2 (en) 2024-12-17
EP3706792A1 (de) 2020-09-16
BR112020007980A2 (pt) 2020-10-20
JP2023169415A (ja) 2023-11-29
KR20200087187A (ko) 2020-07-20
RU2020116222A (ru) 2021-11-18

Similar Documents

Publication Publication Date Title
MX2016012845A (es) Vacuna contra el virus de la diarrea epidemica porcina.
MA46766A (fr) Vaccin antigrippal
MA43762A (fr) Vaccin contre le rsv
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
EP3630130A4 (en) PROCESS FOR GENERATING PERSONALIZED CANCER VACCINES
EP3576751A4 (en) RNA ANTI-CANCER VACCINES
EP3436070A4 (en) AGAINST CANCER, CHIMERIC ANTIGEN RECEPTORS
DK3371316T3 (da) Vacciner mod hepatitis b-virus
PT3283521T (pt) Conjugados de fármacos compreendendo anticorpos contra a claudina 18.2
DK3609535T3 (da) Hbv-vaccine
IL262296A (en) Cancer immunotherapy by immune activation or immune modulation via globo series antigens
CL2018002692A1 (es) Vacuna bivalente contra el virus de gripe porcina.(divisional solicitud 201701961)
EP3700565A4 (en) ADJUVED VACCINES
MX2018016362A (es) Formulaciones de anticuerpo anti-cd19.
DK3603619T3 (da) Vaccineadjuvansformulering
CL2017002031A1 (es) Formulación en polvo nasal para el tratamiento de hipoglicemia
EP3385286A4 (en) VACCINE FANTASY WITH INCREASED IMMUNOGENITY
MX2023001540A (es) Vacunas contra el cancer y metodos de tratamiento que las utilizan.
CL2016002338A1 (es) Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática .
MA46661A (fr) Formulations de vaccin glycoconjugué dirigé contre expec
EP2955192A4 (en) ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
DK2904891T3 (da) Hjul, som danner et forbedret landbrugsredskab
CL2019001522A1 (es) Oligonucleótidos modificados para el tratamiento de una enfermedad poliquística renal.
EP3586869A4 (en) IMMUNOGENIC COMPOSITION TARGETED FOR S100A9
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos